American College of Cardiology: Califf is the Right Choice for FDA Commissioner
Contact: Katie Glenn, email@example.com, 202-375-6472
WASHINGTON (Feb 24, 2016) -
A statement from American College of Cardiology President Kim Allan Williams Sr., M.D., FACC, on the confirmation of Robert Califf, M.D., MACC, as commissioner of the Food and Drug Administration:
"Dr. Califf is an acclaimed leader in the cardiovascular community who brings impressive medical knowledge, clinical research experience and leadership capabilities to the FDA. He has made important contributions to the field of medicine and has the vision required to lead the FDA in its efforts to promote and protect public health. Dr. Califf is the right person to lead the FDA, and the American College of Cardiology congratulates him on his confirmation as the new FDA commissioner," said American College of Cardiology President Kim Allan Williams Sr., M.D., FACC.
The American College of Cardiology is a 52,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more information, visit acc.org.